Alvio Labs

Q1 2026 Management Report

Period

Jan 1 - Mar 31, 2026

Net Profit / Loss

-€4,226.52

Q1 operating loss

Total Expenses

€4,226.52

Cost of Sales: €3,032
OpEx: €1,194

Cash Position

€116.00

-78.2% vs Q1 2025

Equity Position

-€35,940.06

Negative equity

Profit & Loss Breakdown

Q1 2026 by expense category

Loss Position

OpEx Distribution

Consulting & Accounting
€613.00 (51.3%)
Software Expenses
€271.65 (22.7%)
R&D
€191.98 (16.1%)

Balance Sheet Snapshot

As of Mar 31, 2026
Total Assets -78%

€116.00

vs €532.14 in Q1 2025

Current Liabilities

€36,056

+141% YoY

Net Assets

-€35,940

Deteriorated

Liability Breakdown

Director's Current Account

Shubham Jain

€23,697.62

Director's Loan Account

Shubham Jain

€12,550.00

Sales Tax

VAT/GST payable

-€191.56

Accounts Payable

Vendor invoices

€0.00

Cash Flow Alert

Current cash position (€116) is critically low relative to director obligations. Consider capital injection or expense reduction.

Operating Expenses Detail

Q1 2026 transactions by category

Category Account Code Amount (EUR) % of OpEx
Consulting & Accounting b87afffb €613.00 51.3%
Office: Software Expenses db67b44c €271.65 22.7%
Research & Development 963b4aaa €191.98 16.1%
Office Expenses 3561d879 €53.47 4.5%
Subscriptions 1eee64c4 €42.36 3.5%
Travel - National 2af05276 €20.00 1.7%
Bank Fees 32727f7b €1.99 0.2%
Total Operating Expenses €1,194.45 100%

Year-over-Year Comparison

Total Assets

€116 78%

vs €532 in Q1 2025

Current Liabilities

€36,056 141%

vs €14,949 in Q1 2025

Director Loans

€36,248 152%

vs €14,543 in Q1 2025

Net Position

-€35,940 149%

vs -€14,417 in Q1 2025

Accounts Receivable Status

Outstanding customer invoices

All Paid

No Outstanding Invoices

All customer invoices have been paid. There are currently no outstanding receivables requiring collection action.

0

Outstanding

€0.00

Amount Due

A Built with Alvio